Jetblack Corp. (OTCPK: JTBK)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Jetblack Corp. (OTCPK: JTBK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $86.03K and employs 2 people.
trading between 0.00 and 0.00.
Tweenvest scores Jetblack Corp. across four factors: quality 24/100. Its strongest factor is quality.
JTBK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $86.03K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.23
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 860.27M
- Employees
- 2
- Next earnings
- —
About Jetblack Corp.
Jetblack Corp. currently maintains limited operational activities. Its primary strategy involves seeking out and making minority equity investments in burgeoning, high-growth industries, with a particular focus on the digital asset space. This investment approach is designed to bolster the company's asset portfolio and enhance overall shareholder value. Established in 2002, Jetblack Corp. operates from its headquarters in Portland, Oregon.
- ISIN
- US47714A1051
- Founded
- 2002
- Listed since
- Aug 2, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.